An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Cerus (Nasdaq: CERS) will release its first quarter 2024 financial results on May 2, 2024. The company will host a conference call and webcast to discuss the financial results and provide a business outlook.
Cerus (Nasdaq: CERS) pubblicherà i risultati finanziari del primo trimestre del 2024 il 2 maggio 2024. La società organizzerà una conferenza telefonica e un webcast per discutere i risultati finanziari e fornire una prospettiva aziendale.
Cerus (Nasdaq: CERS) publicará sus resultados financieros del primer trimestre de 2024 el 2 de mayo de 2024. La compañía realizará una llamada de conferencia y una transmisión web para discutir los resultados financieros y proporcionar una perspectiva del negocio.
세러스(Cerus, 나스닥: CERS)는 2024년 5월 2일에 2024년도 1분기 재무 결과를 발표할 예정입니다. 회사는 재무 결과를 논의하고 사업 전망을 제공하기 위해 컨퍼런스 콜과 웹캐스트를 주최할 것입니다.
Cerus (Nasdaq : CERS) publiera ses résultats financiers pour le premier trimestre 2024 le 2 mai 2024. L'entreprise organisera une conférence téléphonique et une webdiffusion pour discuter des résultats financiers et fournir une perspective d'affaires.
Cerus (Nasdaq: CERS) wird am 2. Mai 2024 die Finanzergebnisse für das erste Quartal 2024 veröffentlichen. Das Unternehmen wird eine Telefonkonferenz und ein Webcast veranstalten, um die Finanzergebnisse zu besprechen und einen Geschäftsausblick zu bieten.
Positive
None.
Negative
None.
CONCORD, Calif.--(BUSINESS WIRE)--
Cerus Corporation (Nasdaq: CERS) announced today that its first quarter 2024 financial results will be released on Thursday, May 2, 2024, after the close of the stock market. The Company will host a conference call and webcast at 4:30 P.M. ET that afternoon, during which management will discuss the Company’s financial results and provide a general business overview and outlook.
To listen to the live webcast and view the presentation slides, please visit the Investor Relations page of the Cerus website at http://ir.cerus.com. Participants may register for the call here. While not required, interested participants are encouraged to join 10 minutes prior to the start of the event.
A replay will be available on Cerus’ website and will be available approximately three hours after the call through May 23, 2024.
ABOUT CERUS
Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. The INTERCEPT red blood cell system is under regulatory review in Europe, and in late-stage clinical development in the US. Also in the US, the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn.
INTERCEPT and the INTERCEPT Blood System are trademarks of Cerus Corporation.
When will Cerus release its first quarter 2024 financial results?
Cerus will release its first quarter 2024 financial results on May 2, 2024.
What is the ticker symbol for Cerus ?
The ticker symbol for Cerus is CERS.
Where can I listen to the live webcast of the financial results discussion?
You can listen to the live webcast and view the presentation slides on the Investor Relations page of the Cerus website at http://ir.cerus.com.
When will the replay of the conference call be available?
The replay of the conference call will be available on Cerus' website approximately three hours after the call and will be accessible through May 23, 2024.
cerus corporation is a biomedical products company focused on commercializing the intercept blood system to enhance blood safety. the intercept system is designed to reduce the risk of transfusion-transmitted diseases by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. the nucleic acid targeting mechanism of action enables intercept treatment to inactivate established transfusion threats, such as hepatitis b and c, hiv, west nile virus and bacteria, and is designed to inactivate emerging pathogens such as influenza, malaria and dengue. cerus currently markets and sells the intercept blood system for both platelets and plasma in europe, russia, the middle east and selected countries in other regions around the world. the intercept red blood cell system is in clinical development.
